跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ROSIGLITAZONE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ROSIGLITAZONE
Authorized
STANDARD
ROSIGLITAZONE
aa pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
f748d86713cc9ae8
Company
aa pharma inc
Type
Standard
Approval Details
Approval Id
f748d86713cc9ae8
Drug Approval Canada Name
ROSIGLITAZONE
Product Name
ROSIGLITAZONE
Status
Marketed
Status Date
2019-09-17
Original Market Date
2017-02-21
Din
02403366
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
68:20.28
Atc Original
A10BG02 ROSIGLITAZONE
Atc Name
a 10 bg 02
Aig Number
0138802002
Company Name
aa pharma inc
Company Address
UNIT 1, 1165 Creditstone Road, Vaughan, Ontario, Canada, L4K 4N7
Active Ingredients
ROSIGLITAZONE (ROSIGLITAZONE MALEATE)
2 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
f748d86713cc9ae8
Type
Standard
Back to Health Canada Approvals